Pancreatic Medicine

The pancreas often provokes worry before it has been comprehensively examined. My commitment is to replace uncertainty with understanding.

Specialist Outpatient Clinic for Pancreatic DiseasesUniversity Hospital St. Pölten

Paths to an appointment

Bile ductPancreatic ductPancreasDuodenum
Schematic drawing, seen from the front. The head of the pancreas lies in the curve of the duodenum. The bile duct runs through the head and usually opens into the duodenum together with the pancreatic duct.

The pancreas is a central metabolic organ, responsible for regulating blood sugar and digesting food. For many patients, however, it is above all something else: an organ that provokes worry. Whether it is an indeterminate cyst on an ultrasound, an inflammation without obvious cause, or a family history of disease: I see again and again in consultations how burdensome this uncertainty can be.

Since 2018 I have been part of the team at one of the few internal medicine-led specialist outpatient clinics (Spezialambulanz) for pancreatic diseases in Austria, based at the University Hospital St. Pölten. These years of focused experience shape my approach: structured investigation, honest communication, and shared decisions, without premature conclusions.

Behind the diagnosis

What preoccupies me time and again is what is easily overlooked behind a diagnosis: in acute and chronic inflammation of the pancreas, causes are often attributed to diet or alcohol, sometimes rightly so, but often that is not the full picture. Underlying factors can include genetic variants, autoimmune conditions such as autoimmune pancreatitis, anatomical differences, or metabolic disorders that are treatable.

The question of familial clustering of pancreatic cancer also requires careful differentiation: only a proportion of cases represent true familial pancreatic cancer (FPC). But that distinction carries far-reaching consequences for surveillance and prevention. And one more thing deserves to be said openly: those living with chronic pancreatitis often carry a quiet worry about pancreatic cancer. The risk is higher than in the general population, but in absolute terms it remains small for most people affected — which is precisely why it is better to talk about it than to avoid it. What applies in an individual case, and whether surveillance makes sense, is something we discuss together.

Autoimmune pancreatitis (AIP)

A particular focus of my outpatient clinic work is autoimmune pancreatitis (AIP): a rare inflammation of the pancreas driven by the body’s own immune system. My main attention is on type 1, which, as part of IgG4-related disease, can also affect other organs such as the bile ducts. Many patients are first confronted with the suspicion of a tumour. That makes a diagnosis that stands on solid ground all the more important: autoimmune pancreatitis is treatable and usually responds quickly to cortisone. Relapses, however, are common. A relapse does not mean that something was done wrong, and it can be treated again. What matters is therefore assessing the individual risk correctly from the start. In the department where I work, gastroenterology and rheumatology care for these patients jointly; where the risk is elevated, for example when several organs are involved, the team weighs in each individual case whether modern antibody therapies make sense early in the course of the disease. I wrote the internal treatment protocol for type 1 autoimmune pancreatitis for our centre. The question of who needs which therapy, when, and for how long is also the subject of my scientific work.

Pain in pancreatic disease

Pain in chronic pancreatitis or pancreatic cancer is real, often severe, and it is frequently undertreated. I take it seriously as a treatment goal in its own right. The first step is to look for treatable causes: strictures or stones in the pancreatic duct, for example, can be treated endoscopically, with a stent or stone removal. Sometimes, however, the most effective pain therapy is surgery. Recognising this indication in time, before the pain becomes self-sustaining in the nervous system and a pain memory develops, is one of the most important decisions in care; here I involve experienced surgeons from my network early. And where the pain has no such treatable cause, the task is to find the right combination of medications for the individual person, embedded in a multimodal approach that does not rely on medication alone. For this I work with the team of a practice specialised in pain medicine (schmerzmedizin.at); my focus there is visceral pain, that is, pain arising from the internal organs. Throughout, the guidance remains with me.

For patients who require further investigation or specialised guidance, I can draw on a network of colleagues in radiology, endoscopy, and surgery. What always remains at the centre is the conversation, because informed decisions are better decisions.

What I offer

Pancreatic lipomatosis

Fatty infiltration of the pancreas as a metabolic warning signal

  • assessment of individual cardiovascular risk
  • metabolic investigation and optimisation
  • preventive medical guidance

Pancreatic cysts

From reassurance to structured surveillance — including IPMN (intraductal papillary mucinous neoplasm) and other cystic lesions

  • risk stratification by imaging and, where appropriate, endoscopic ultrasound (EUS)
  • at low risk: reassurance or structured follow-up
  • at risk of malignant transformation: interdisciplinary care together with experienced surgeons

Acute pancreatitis

Care beyond the acute phase

  • investigation of causes (including genetic, metabolic, and anatomical factors)
  • structured follow-up and management of complications (pseudocysts, necrosis, endocrine and exocrine pancreatic insufficiency)
  • endoscopic therapy at the centre in St. Pölten
  • metabolic management

Chronic pancreatitis

Comprehensive guidance

  • investigation of causes with a focus on treatable triggers (genetics, autoimmunity, anatomical variants)
  • management of complications (endoscopic or surgical)
  • metabolic care for pancreatogenic diabetes arising from chronic pancreatic disease, including insulin therapy
  • nutritional support for malnutrition and weight loss

Autoimmune pancreatitis (AIP)

Rare, but treatable: a focus of my outpatient clinic work

  • securing the diagnosis, with clear distinction from pancreatic cancer
  • classification: type 1 (IgG4-related disease, potentially involving other organs) or type 2
  • cortisone therapy with a plan: response, dose reduction, duration
  • modern antibody therapies (rituximab, inebilizumab): for relapses and, depending on individual risk, early in the course of the disease
  • long-term care with monitoring of pancreatic function (digestion and blood sugar)

Pain in pancreatic disease

Taken seriously as a treatment goal in its own right

  • targeted investigation of treatable causes of pain (strictures or stones in the pancreatic duct)
  • endoscopic therapy where the anatomy makes it worthwhile (stent, stone removal)
  • timely recognition of the indication for surgery, before pain becomes chronic, with referral to experienced surgeons
  • pharmacological pain therapy: the right combination for the individual patient
  • multimodal pain management in collaboration with a specialised pain medicine practice (schmerzmedizin.at)

Familial clustering of pancreatic cancer

Structured investigation and care

  • classification: is it true familial pancreatic cancer (FPC)?
  • individual risk assessment
  • radiological and endoscopic surveillance, where appropriate
  • lifestyle optimisation